When the AI Becomes the Attack Surface: Healthcare Cybersecurity Risks in AI Systems
Key Concept: Healthcare Cybersecurity Risks in AI Systems
Date: August 25, 2026
by Ph. D. Giljae Lee
Artificial intelligence is becoming embedded in clinical decision-making, radiology workflows, patient communication, operational analytics, and medical-device software. Yet the security problem is changing faster than many hospital security programs.
A conventional cyberattack attempts to steal information, disrupt availability, or obtain unauthorized access. An attack against an AI-enabled clinical system can do something more subtle: alter the information on which a clinical decision is based without obviously breaking the system itself.
Consider an imaging department in which an AI algorithm analyzes CT studies for pulmonary embolism. The PACS remains available. The DICOM study opens normally. The algorithm returns a result. The radiologist sees the familiar interface. But if an attacker has manipulated the model, its input pipeline, model weights, inference environment, or clinical integration layer, the most dangerous failure may be an output that appears perfectly legitimate.
That distinction changes cybersecurity from an IT problem into a patient-safety problem.
Healthcare organizations therefore need to protect not only networks and databases, but the integrity of the entire AI decision pathway.
1. The AI Attack Surface Is Larger Than the Model
The common mistake is to think of an AI system as a model surrounded by a conventional cybersecurity perimeter. In practice, clinical AI is a chain of dependencies.
A radiology AI workflow may involve:
Every transition introduces another opportunity for failure.
The model itself can be attacked through techniques such as evasion attacks, data poisoning, backdoors, model manipulation, or adversarial inputs. NIST's adversarial machine-learning taxonomy explicitly identifies attack stages, attacker objectives, capabilities, and mitigation strategies across the AI lifecycle.
But the model is only one component.
A compromised DICOM router could potentially affect what reaches an algorithm. A vulnerable API could expose inference services. Excessive privileges could allow unauthorized modification of models or configurations. A poorly controlled cloud connection could create a pathway from an external service into a hospital environment.
Generative AI introduces additional concerns. A clinical large language model may receive patient information through an application layer, retrieve documents from an enterprise knowledge base, invoke external APIs, and generate recommendations. The security boundary is therefore distributed across data, prompts, retrieval systems, models, applications, users, and vendors.
The practical implication is uncomfortable: a secure model cannot compensate for an insecure clinical ecosystem.
Figure 1. Healthcare AI Cyberattack Surface
This is also where interoperability becomes a security issue rather than merely an integration issue. HL7/FHIR interfaces, authentication services, identity providers, APIs, and service accounts must be treated as part of the clinical attack surface.
[Internal cross-reference: See the related column on Building Trustworthy AI Monitoring Pipelines Using FHIR and DICOM Standards for a deeper discussion of interoperability and continuous monitoring.]
2. Why Traditional Hospital Cybersecurity Controls Are Not Enough
Healthcare already has serious cybersecurity exposure. ENISA's health-sector analysis identified ransomware as a major threat and reported that healthcare providers, particularly hospitals, were heavily affected by cyber incidents. Its more recent health-sector overview continues to identify ransomware and data breaches among major threats.
AI adds another dimension: integrity.
For an ordinary information system, a successful attack may be detected because a server stops responding or files become encrypted. An AI attack may instead produce a clinically plausible but incorrect result.
This creates three security objectives that deserve equal attention:
Confidentiality: preventing unauthorized disclosure of protected health information and proprietary clinical data.
Availability: ensuring that AI-dependent clinical services remain operational when clinicians need them.
Integrity: ensuring that data, models, configurations, and AI outputs have not been maliciously altered.
The third objective is particularly important in clinical AI.
Imagine an AI model whose sensitivity silently deteriorates after a model update. If the hospital measures only uptime and cybersecurity incidents, the system may appear healthy. Yet the clinical performance has changed.
This is why cybersecurity monitoring and AI performance monitoring should converge.
A mature hospital should be able to answer questions such as:
Who changed the model or inference configuration?
Which model version generated this clinical result?
Was the input data altered before inference?
Did model performance change after a software update?
Did an unusual user or service account access the model?
Can the organization reconstruct the complete decision pathway after an incident?
NIST's AI Risk Management Framework provides a useful foundation because it treats AI risk management as a lifecycle activity rather than a one-time certification exercise. NIST's Cybersecurity Framework 2.0 similarly emphasizes governance, risk identification, protection, detection, response, and recovery across organizational cybersecurity programs.
The important architectural principle is therefore:
AI governance and cybersecurity governance should share the same risk register for clinically consequential systems.
Table 1. Healthcare AI Cybersecurity Risk-Control Matrix
| AI Component | Attack Vector | Clinical Consequence | Detection Mechanism | Human Verification | Containment Action | Audit Evidence |
|---|---|---|---|---|---|---|
| Clinical Imaging Data / DICOM | DICOM manipulation, malicious metadata, image tampering, adversarial perturbation | Incorrect AI interpretation; missed or falsely reported pathology | DICOM integrity checks, checksum validation, image-quality monitoring, anomaly detection | Radiologist reviews original images and compares AI input with source study | Quarantine suspicious studies; disable automated inference for affected data | DICOM audit logs, hashes, accession records, image provenance |
| AI Training Dataset | Data poisoning, mislabeled cases, unauthorized dataset modification | Systematic model bias, degraded sensitivity/specificity, unsafe predictions | Dataset version control, statistical drift analysis, label-quality audits | Clinical domain expert reviews suspicious samples and performance changes | Freeze affected dataset/model version; restore validated dataset | Dataset hashes, version history, labeling records, approval logs |
| AI Model / Model Weights | Model poisoning, backdoor insertion, unauthorized modification | Silent false negatives/positives; unsafe clinical recommendations | Cryptographic signatures, model hash verification, performance monitoring | Clinical validation against reference cases and benchmark datasets | Revert to last validated model; suspend AI output if integrity is uncertain | Model registry, checksum/signature, deployment history, validation report |
| Inference Server | Remote exploitation, privilege escalation, malware, unauthorized configuration change | AI unavailable or produces manipulated outputs | EDR/XDR, SIEM monitoring, process anomaly detection, configuration monitoring | IT security and clinical AI teams assess affected inference results | Isolate server; fail over to validated backup or manual workflow | Server logs, security alerts, configuration snapshots, forensic images |
| AI API / Integration Layer | API abuse, credential theft, injection, unauthorized requests | Incorrect patient-model association; delayed or incorrect clinical result | API gateway monitoring, authentication logs, rate-limit alerts, anomaly detection | Verify patient ID, accession number, request origin, and returned result | Revoke credentials; block endpoint; route cases to manual review | API logs, authentication records, request/response metadata |
| HL7 / FHIR Interface | Message manipulation, unauthorized API access, identity mismatch | AI findings linked to wrong patient or clinical context | Message validation, identity reconciliation, FHIR audit logging | Clinician verifies patient identity and clinical context before acting | Stop affected interface; quarantine messages; perform reconciliation | HL7/FHIR transaction logs, audit events, identity records |
| PACS / VNA Integration | Compromised service account, unauthorized routing, ransomware | AI receives incomplete/wrong studies; diagnostic workflow disruption | Network monitoring, routing-rule validation, access logs | Radiologist confirms study completeness and correct patient association | Disable compromised routing path; activate manual PACS workflow | Access logs, routing configuration, DICOM audit trail |
| Generative AI / Clinical LLM | Prompt injection, maliciously retrieved content, data exfiltration, jailbreak | Unsafe recommendation, hallucinated clinical information, PHI disclosure | Prompt/output monitoring, retrieval-source validation, DLP, anomaly detection | Physician verifies clinically consequential outputs against trusted sources | Block session/tool access; disable external retrieval; preserve conversation logs | Prompt/output logs, retrieval provenance, user identity, tool-call history |
| RAG / Clinical Knowledge Base | Malicious document insertion, unauthorized content modification | Incorrect clinical guidance generated from contaminated evidence | Document provenance checks, content hashing, source validation | Clinician verifies cited evidence and source authority | Remove/quarantine compromised documents; rebuild index | Document hashes, source metadata, indexing logs, approval history |
| Cloud AI Infrastructure | Cloud credential compromise, insecure storage, exposed endpoints | PHI exposure; AI service manipulation or outage | CSPM, IAM monitoring, cloud audit logs, network anomaly detection | Security team and clinical AI owner assess affected services | Revoke credentials; isolate resources; activate disaster recovery | CloudTrail/audit logs, IAM records, configuration snapshots |
| Third-Party AI Vendor | Supply-chain compromise, vulnerable software dependency, vendor breach | Compromised model behavior, service interruption, patient-data exposure | Vendor security monitoring, SBOM review, vulnerability scanning, performance surveillance | Hospital validates vendor update before clinical deployment | Suspend vendor connection/model; revert to approved version | Vendor assessment, SBOM, contracts, security attestations, validation records |
| AI Monitoring System | Log tampering, monitoring bypass, alert suppression | Security incident remains undetected; delayed clinical response | Immutable logging, SIEM correlation, independent monitoring | Security analyst validates anomaly against clinical events | Protect monitoring infrastructure; preserve forensic logs | Immutable logs, SIEM records, alert history, timestamped evidence |
| User / Administrator Account | Phishing, credential theft, insider misuse, privilege abuse | Unauthorized model/configuration changes or PHI exposure | MFA, UEBA, privileged-access monitoring, impossible-travel alerts | Verify user activity and authorization with department owner | Disable account; revoke tokens; rotate credentials | Authentication logs, IAM records, access approvals |
| AI Clinical Output | Output manipulation, post-inference alteration, integration-layer tampering | Incorrect diagnosis, prioritization, or treatment recommendation | Output integrity checks, result-to-source reconciliation, discrepancy monitoring | Radiologist/clinician independently evaluates clinically significant findings | Suppress affected outputs; require manual interpretation | AI result version, source images/data, clinician sign-off, timestamps |
This approach also helps address a common organizational problem: cybersecurity teams may classify an incident as a technical event while clinicians experience it as a patient-safety event.
Those classifications cannot remain disconnected.
3. Building a Clinically Resilient AI Security Architecture
Security controls should ultimately be judged by one question:
Can the hospital safely continue clinical operations when the AI system cannot be trusted?
This requires resilience rather than simply prevention.
The first layer is identity and access control. AI models, service accounts, APIs, administrators, vendors, and clinicians should receive only the privileges required for their roles. Model repositories and inference infrastructure deserve the same rigor applied to other critical clinical systems.
The second is model and software supply-chain security. Hospitals increasingly depend on commercial AI vendors, open-source libraries, cloud services, pretrained models, and third-party components. The FDA's current medical-device cybersecurity guidance emphasizes cybersecurity throughout device design and lifecycle management, including documentation and vulnerability management for applicable cyber devices.
The third is continuous validation.
A clinically deployed model should not be considered permanently validated simply because it passed an evaluation before deployment. Security events, data drift, software changes, population changes, and model updates can all alter clinical behavior.
The fourth is human fallback.
If an AI system flags intracranial hemorrhage, pulmonary embolism, or pneumothorax, the clinical workflow must remain safe when the algorithm becomes unavailable—or when its integrity is uncertain. A radiologist should never be placed in a position where an AI outage effectively removes the only practical diagnostic pathway.
This is particularly important because excessive cybersecurity alerts can create another problem: alert fatigue.
If every unusual AI event generates a high-priority clinical notification, physicians will eventually stop distinguishing meaningful warnings from background noise. Security monitoring should therefore be risk-based, correlating technical anomalies with clinical context.
For example, a minor API anomaly may require investigation. A simultaneous API anomaly, model-version change, unusual administrator login, and sudden alteration in false-negative rates should trigger immediate escalation.
The goal is not to generate more alerts.
It is to generate better evidence for decisions.
Internal cross-reference: See the related discussion on Enterprise Clinical AI Governance Frameworks for Large Hospital Networks for governance structures, escalation pathways, and accountability models.
A practical hospital AI security baseline
Healthcare organizations deploying clinically consequential AI should consider establishing:
Asset-level AI inventories covering models, datasets, APIs, interfaces, vendors, and dependencies.
Version-controlled model registries with immutable audit trails.
Strong identity and least-privilege access for users, services, and vendors.
DICOM, HL7, and FHIR integrity monitoring across clinical interfaces.
Software bills of materials and supplier-risk assessments for applicable systems.
Adversarial testing and red-team exercises before and after major releases.
Independent clinical validation after significant model or workflow changes.
AI-specific incident response playbooks linking cybersecurity, clinical safety, legal, compliance, and executive teams.
Downtime and degraded-mode procedures that allow clinicians to continue safely without AI.
Post-incident forensic reconstruction, including model version, input provenance, configuration, user identity, and output history.
HHS's Healthcare and Public Health Cybersecurity Performance Goals provide another practical starting point for organizations seeking high-impact cybersecurity controls rather than an enormous collection of disconnected requirements.
The deeper lesson is that AI security cannot be outsourced completely to the vendor. Hospitals own the clinical consequences of deployment even when they do not own the underlying algorithm.
Conclusion: Secure AI Must Remain Clinically Trustworthy
Healthcare AI security should no longer be framed simply as protecting sensitive data from hackers.
The more consequential question is whether a hospital can trust the computational pathway connecting patient data to clinical action.
That means protecting confidentiality, availability, and integrity—but also preserving provenance, model accountability, human oversight, and clinical fallback mechanisms.
WHO's guidance on AI for health places human autonomy, safety, accountability, transparency, and continuous assessment at the center of responsible AI governance. Those principles become particularly important when cybersecurity failures can directly influence diagnosis or treatment.
The future hospital will therefore need something more sophisticated than a firewall around an AI application. It will need a clinically aware AI security architecture in which cybersecurity telemetry, model-performance monitoring, clinical validation, identity management, and incident response operate as a connected system.
The most trustworthy AI system is not the one that claims to be impossible to attack.
It is the one designed so that when an attack, failure, or unexpected behavior occurs, the hospital can detect it, contain it, explain what happened, and continue caring for the patient safely.
Frequently Asked Questions
1. Why is AI cybersecurity different from conventional healthcare cybersecurity?
Traditional cybersecurity often focuses on confidentiality, system availability, and unauthorized access. AI introduces additional risks involving model integrity, training-data manipulation, adversarial inputs, model drift, and malicious alteration of AI outputs.
2. Can an AI model be secure but the clinical AI system still be vulnerable?
Yes. A well-secured model can still be compromised through its data pipeline, APIs, DICOM interfaces, identity systems, cloud infrastructure, software dependencies, or clinical integration layer.
3. What is the most dangerous AI cybersecurity failure in radiology?
A particularly concerning scenario is a clinically plausible false result that is not recognized as a cybersecurity event. Unlike an obvious system outage, silent alteration of model behavior may continue until a clinical discrepancy is identified.
4. Should hospitals monitor AI model performance as part of cybersecurity?
Yes. Significant changes in false-negative rates, output distributions, latency, confidence patterns, or data characteristics may provide useful signals of technical malfunction, data drift, configuration changes, or malicious interference.
5. What role does the FDA play in AI cybersecurity?
For applicable medical devices, FDA cybersecurity requirements and guidance address cybersecurity design, documentation, vulnerability management, and lifecycle considerations. The FDA's February 2026 final guidance supersedes its June 2025 version.
6. Is FHIR itself a cybersecurity solution?
No. FHIR is an interoperability standard. Secure implementation requires appropriate authentication, authorization, transport security, access controls, auditability, and careful API governance.
7. What should happen when an AI system is suspected of being compromised?
The organization should have a predefined escalation pathway that can isolate or disable the affected AI function, preserve forensic evidence, activate clinical fallback procedures, assess affected patients, and coordinate cybersecurity and clinical leadership.
Recommended Reading
E. Tabassi, Artificial Intelligence Risk Management Framework (AI RMF 1.0), NIST AI 100-1, National Institute of Standards and Technology, 2023.
C. Pascoe, S. Quinn, and K. Scarfone, The NIST Cybersecurity Framework (CSF) 2.0, NIST Cybersecurity White Paper 29, National Institute of Standards and Technology, 2024.
A. Vassilev, A. Oprea, A. Fordyce, H. Anderson, X. Davies, and M. Hamin, Adversarial Machine Learning: A Taxonomy and Terminology of Attacks and Mitigations, NIST AI 100-2e2023, National Institute of Standards and Technology, 2025.
U.S. Food and Drug Administration, Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions, Final Guidance, Feb. 2026.
European Union Agency for Cybersecurity, ENISA Threat Landscape: Health Sector, European Union Agency for Cybersecurity, Jul. 2023.
World Health Organization, Ethics and Governance of Artificial Intelligence for Health: WHO Guidance, Geneva, Switzerland, 2021.
U.S. Department of Health and Human Services, Healthcare and Public Health Cybersecurity Performance Goals, HHS Cyber Gateway.
Comments
Post a Comment